Exploratory Clinical Trial of Oral Paclitaxel Plus Radiotherapy in Patients With Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma

This study tests oral paclitaxel (a chemotherapy drug taken by mouth) combined with radiotherapy in older or frail patients with locally advanced oesophageal squamous cell carcinoma who cannot tolerate standard intravenous chemotherapy. **You may be eligible if...** - You are 70 years or older, or younger but unable to tolerate standard IV chemotherapy due to other health conditions - You have locally advanced oesophageal squamous cell carcinoma (confirmed by biopsy) that cannot be surgically removed - You have significant difficulty swallowing or eating due to the tumour - You are considered suitable for definitive chemoradiotherapy (radiation plus chemotherapy as the main treatment) **You may NOT be eligible if...** - Your cancer has spread to distant organs - You are in very poor health and cannot tolerate any chemotherapy or radiation - You have recently received other cancer treatments that would interfere with this trial Talk to your doctor to see if this trial is right for you.